Korean J Gastroenterol.
2019 Apr;73(4):202-206. 10.4166/kjg.2019.73.4.202.
Systemic Therapy for Advanced and Metastatic Colon Cancer
- Affiliations
-
- 1Division of Gastroenterology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea. jaejpark@yuhs.ac
- KMID: 2443632
- DOI: http://doi.org/10.4166/kjg.2019.73.4.202
Abstract
- Colon cancer is one of the three most common cancers in both men and women in Organization for Economic Cooperation and Development countries. Approximately one-quarter of colon cancer patients have a metastasis at the time of diagnosis, and systemic therapy is used in many of them as a first line therapy. In addition to existing cytotoxic drugs, target therapy has been introduced in colon cancer and immunotherapy has shown clinical benefits in the treatment of metastatic colon cancer. The purpose of this review was to briefly summarize the National Comprehensive Cancer Network guidelines for systemic therapy in colon cancer with special reference to targeted agents and novel agents.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Exploring the Evolving Role of Metastasectomy in Advanced Renal Cell Carcinoma
- Complete response to local therapy for advanced hepatocellular carcinoma with lung metastasis: a case report
- Successful Treatment of Advanced Gastric Cancer with Brain Metastases through an Abscopal Effect by Radiation and Immune Checkpoint Inhibitor Therapy
- A Case of Multiple Colon Ulcers due to Complications of S-1 (TS-1)
- From Control to Conversion: Optimizing Systemic Therapy for Curative-Intent Conversion Surgery in Metastatic Gastric Cancer
